EMPATH HOME HEALTH DIVISION, INC. – Trademark Portfolio
Entity Type: 54
EMPATH HOME HEALTH DIVISION, INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AVIDITY and APPROVED. The owner is based in LAKEWOOD RANCH,, FL.
6310 CAPITAL DRIVE
LAKEWOOD RANCH,, FL 34202
Showing of trademarks Trademarks
Trademark Classifications
EMPATH HOME HEALTH DIVISION, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Legal services; security services for the protection of property and individuals
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does EMPATH HOME HEALTH DIVISION, INC. have?
EMPATH HOME HEALTH DIVISION, INC. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does EMPATH HOME HEALTH DIVISION, INC. file in?
EMPATH HOME HEALTH DIVISION, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 45 (Legal & Security Services), Class 44 (Medical Services). Class 45 covers legal services; security services for the protection of property and individuals.
What are EMPATH HOME HEALTH DIVISION, INC.'s most well-known trademarks?
EMPATH HOME HEALTH DIVISION, INC.'s registered trademark portfolio includes well-known marks such as AVIDITY and APPROVED. These are among 2 currently registered trademarks in the portfolio.
What is EMPATH HOME HEALTH DIVISION, INC.'s trademark registration success rate?
EMPATH HOME HEALTH DIVISION, INC. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.